Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Clinical trial NCT00265928 · TERMINATED
Trial details
- NCT number
- NCT00265928
- Sponsor
- University of Virginia
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.